Skip to main content
FDA Shortage Check

Is Fentanyl Citrate Injection in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Fentanyl Citrate Injection: in shortage

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Demand increase for the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Reason: “Other”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated Recovery: December 2026”. Manufacturer’s estimate, Hospira, Inc., a Pfizer Company, Oct 21, 2026
DRUG
Fentanyl Citrate Injection
FDA LISTING
FORM
injection
STATUS
Currently in Shortage
FIRST POSTED
Jan 1, 2012
LAST FDA UPDATE
Oct 21, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 20 presentations: 3 unavailable · 3 limited · 14 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Fentanyl Citrate Injection. 20 presentations from 3 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Hikma Pharmaceuticals USA, Inc.8 presentations · 3 unavailable · 5 available or not stated

Contact (FDA's listing): 800-631-2174

  • 50 ug/1 mL

    Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6024-10)

    Inventory available in vial presentations.

    NDC 0641-6024-10Reverified

    Unavailable

  • 50 ug/1 mL

    Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6025-10)

    Inventory available in vial presentations.

    NDC 0641-6025-10Reverified

    Unavailable

  • 50 ug/1 mL

    Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6026-05)

    Inventory available in vial presentations.

    NDC 0641-6026-05Reverified

    Unavailable

  • 50 mcg/1 mL

    Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6027-25)

    Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.

    NDC 0641-6027-25Reverified

    Available

  • 50 mcg/1 mL

    Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6028-25)

    Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.

    NDC 0641-6028-25Reverified

    Available

  • 50 mcg/1 mL

    Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6029-25)

    Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.

    NDC 0641-6029-25Reverified

    Available

  • 50 mcg/1 mL

    Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6030-01)

    Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.

    NDC 0641-6030-01Reverified

    Available

  • 50 mcg/1 mL

    Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6247-25)

    Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.

    NDC 0641-6247-25Reverified

    Available

Hospira, Inc., a Pfizer Company6 presentations · 3 limited · 3 available or not stated

Contact (FDA's listing): 844-646-4398

  • 1000 mcg/20 mL (50 ug/1 mL)

    Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31)

    Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026

    NDC 0409-9094-31Revised

    Limited Availability

  • 250 mcg/5 mL (50 ug/1 mL)

    Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25)

    Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026

    NDC 0409-9094-25Revised

    Limited Availability

  • 500 mcg/10 mL (50 ug/1 mL)

    Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28)

    Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026

    NDC 0409-9094-28Revised

    Limited Availability

  • 100 mcg/2 mL (50 ug/1 mL)

    Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22)

    NDC 0409-9094-22Revised

    Available

  • 2,500 mcg/50 mL (50 mcg/mL) Single Dose Glass Fliptop Vial

    Fentanyl Citrate, Injection, 2,500 mcg/50 mL (50 mcg/mL) Single Dose Glass Fliptop Vial (NDC 0409-9094-55)

    NDC 0409-9094-55Revised

    Available

  • 2500 mcg/50 mL (50 ug/1 mL)

    Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61)

    NDC 0409-9094-61Revised

    Available

Fresenius Kabi USA, LLC6 presentations · 6 available or not stated

Contact (FDA's listing): 888-386-1300

  • .05 mg/1 mL

    Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01)

    Check wholesalers for inventory

    NDC 63323-806-01Reverified

    Available

  • .05 mg/1 mL

    Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02)

    Check wholesalers for inventory

    NDC 63323-806-02Reverified

    Available

  • .05 mg/1 mL

    Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05)

    Check wholesalers for inventory

    NDC 63323-806-05Reverified

    Available

  • .05 mg/1 mL

    Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20)

    Check wholesalers for inventory

    NDC 63323-806-20Reverified

    Available

  • .05 mg/1 mL

    Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50)

    Check wholesalers for inventory

    NDC 63323-806-50Reverified

    Available

  • 50 ug/1 mL

    Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11)

    Check wholesalers for inventory

    NDC 63323-808-11Reverified

    Available

What the manufacturers told FDA

  • Hospira, Inc., a Pfizer Company · ‘Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026’ · updated Oct 2026
  • Hospira, Inc., a Pfizer Company · ‘Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Demand increase for the drug
  • Other

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Fentanyl Citrate Injection in shortage?
Yes. As of Oct 24, 2026, FDA lists Fentanyl Citrate Injection as currently in shortage: 20 presentations, 3 unavailable and 3 limited.
When will the Fentanyl Citrate Injection shortage end?
FDA gives no end date. 3 presentations carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Fentanyl Citrate Injection?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.